Evidence map›Paper›PMID 34422375›Full record

ReviewJournal of thoracic disease2021

Pleural abnormalities in COVID-19: a narrative review.

Biplab K Saha, Woon H Chong, Adam Austin, Ritu Kathuria, Praveen Datar, Boris Shkolnik, Scott Beegle, Amit Chopra

Abstract readReview
In one paragraph

Review in Journal of thoracic disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Biplab K SahaDepartment of Pulmonary and Critical Care Medicine, Ozarks Medical Center, West Plains, MO, USA.
Woon H ChongDepartment of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, NY, USA.
Adam AustinDepartment of Pulmonary and Critical Care Medicine, University of Florida, Gainesville, FL, USA.
Ritu KathuriaDepartment of Infectious Disease, Ozarks Medical Center, West Plains, MO, USA.
Praveen DatarDepartment of Pulmonary and Critical Care Medicine, Ozarks Medical Center, West Plains, MO, USA.
Boris ShkolnikDepartment of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, NY, USA.
Scott BeegleDepartment of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, NY, USA.
Amit ChopraDepartment of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis narrative review aims to provide a detailed overview of pleural abnormalities in patients with coronavirus disease 19 or COVID-19.

backgroundSevere acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is a novel beta coronavirus responsible for COVID-19. Although pulmonary parenchymal and vascular changes associated with COVID-19 are well established, pleural space abnormalities have not been the primary focus of investigations.

methodsNarrative overview of the medical literature regarding pleural space abnormalities in COVID-19. The appropriate manuscripts were identified by searching electronic medical databases and by hand searching the bibliography of the identified papers. Pleural abnormalities on transverse and ultrasound imaging are discussed. The incidence, clinical features, pathophysiology, and fluid characteristics of pleural effusion are reviewed. Studies reporting pneumothorax and pneumomediastinum are examined to evaluate for pathogenesis and prognosis. A brief comparative analysis of pleural abnormalities among patients with COVID-19, severe acute respiratory syndrome (SARS), and Middle Eastern respiratory syndrome (MERS) has been provided.

conclusionsRadiologic pleural abnormalities are common in COVID-19, but the incidence of pleural effusion appears to be low. Pneumothorax is rare and does not independently predispose the patient to worse outcomes. SARS-CoV-2 infects the pleural space; however, whether the pleural fluid can propagate the infection is unclear.

Indexed as

COVID-19pleurapleural effusionpneumothoraxradiology

Identifiers

PMID34422375
PMCPMC8339774

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.